PacBio

Pacific Biosciences of California, Inc. (PacBio) is a biotechnology company based in Menlo Park, California, founded in 2004. The company specializes in advanced genomic sequencing technologies, aiming to enhance human health through comprehensive genomic insights. PacBio's innovative Single Molecule, Real-Time (SMRT) sequencing technology allows for long-read, high-accuracy sequencing, which is essential for analyzing complex genetic regions. PacBio develops and markets a range of DNA sequencing systems, including the PacBio RS, RS II, Sequel System, and Revio System. Their flagship HiFi sequencing technology combines long-read lengths with high accuracy, enabling detailed genomic analysis. The company also offers short-read sequencing solutions following its acquisition of Omniome. PacBio serves a diverse clientele, including academic researchers, clinical laboratories, and pharmaceutical companies, supporting research in human health, rare genetic disorders, agricultural genomics, and more. The company values curiosity, customer satisfaction, and teamwork, reflecting its commitment to innovation and collaboration in the field of genomics.